$BUD

What Anheuser-Busch InBev SA/NV (BUD) Said on Its Q3 Earnings Call

Anheuser-Busch InBev (BUD) reported Q3 earnings, highlighting 35% revenue growth in non-alcohol beer, led by Corona Zero and Michelob ULTRA Zero. Michelob ULTRA expanded internationally, with 60% of its growth outside the U.S. North America saw share gains in beer and Beyond Beer, while Mexico, Colombia, and Brazil reported growth. Europe was flat, and China faced challenges with a 16.8% decline. The company's digital platforms processed $15.9B in GMV, up 12%.

Original reporting
Published Oct 30, 2026, 4:14 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 4:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
What Anheuser-Busch InBev SA/NV (BUD) Said on Its Q3 Earnings Call — source image
Decision brief

The 30-second read

$BUDBullishMed
01

Why it matters

Earnings show divergent regional performance; the buyback signals confidence, but China weakness may drag the stock in the short term.

02

Market read

AB InBev's Q3 earnings provide fresh data on global beer demand, influencing consumer‑goods and beverage sector sentiment.

03

What to watch

The impact of the BEES B2B platform growth and the upcoming hedging program could improve margins later in 2027.

Relevance 8/10Novelty 8/10Timing: after‑hours Q3 earnings release

Background

AB InBev reported Q3 results, highlighting strong non‑alcohol beer growth, a significant decline in China, and a continued share‑repurchase program.

Company-level read

Ticker impact

$BUDBullishHigh confidence
Context

Q3 earnings call disclosed 35% revenue growth in non-alcohol beer, 16.8% volume decline in China, and a $2.6B share repurchase, providing fresh material for the stock.

Expected impact

potential modest downside as investors weigh China weakness against buyback support

Evidence & confidence

China volume drop is a near‑term drag; however, the $2.6B repurchase and solid non‑alcohol growth could limit downside and may attract value buyers.

Market effects

Beer sector may see renewed focus on non‑alcohol growth as a hedge against soft alcohol demand in China.

European and North American markets could see modest gains from AB InBev's buyback, while Asian markets may be pressured by China weakness.

AB InBev's size means its earnings can influence global consumer‑goods sentiment, especially on non‑alcohol trends.

Counterpoint

Investors could short the stock anticipating broader Asian weakness outweighs the buyback and non‑alcohol upside.

Key entities

  • Michel

    Spokesperson discussing growth and China challenges.

  • Tennenbaum

    CFO commenting on balance sheet and buyback.

Related articles

$BUDMedAI 8/10

Anheuser-Busch InBev Profit Per Share Up 22%

Anheuser-Busch InBev reported a 22.4% rise in underlying profit per share to $1.21 in Q3 2026, with revenue up 4.9% organically to $16.5 billion. The company's shares trade in New York, Brussels, and Johannesburg. The increase in profit was driven by higher prices and premium brands, not volume growth. The company also announced a higher interim dividend and completed part of its share buyback program.

$BUDHighAI 8/10

Anheuser-Busch InBev SA/NV (BUD) (Q3 2026) Earnings Call Highlights: EPS Jumps 22%

Anheuser-Busch InBev (BUD) reported Q3 2026 earnings with EPS up 22%, but faced challenges in China and Brazil. Revenue in China declined 16.8% due to weather and industry issues, while EBITDA rose 3.9% with flat margins. The company cited commodity cost pressures, particularly in the U.S. CEO Michel Doukeris highlighted growth in non-alcoholic beer and ready-to-drink beverages, now above 1.5% of the business.

$BUDMed

AB InBev (BUD) Q3 2026 Earnings Call Transcript

AB InBev (BUD) reported Q3 2026 earnings, highlighting share gains, revenue growth, and strategic investments. Key brands like Michelob ULTRA and Busch Light drove beer performance, while Beyond Beer portfolio grew by low teens. Revenue increased by 4.9%, with underlying EPS up 22%. The company announced an interim dividend of 40 euro cents per share and continues a $6 billion share buyback program. Challenges were noted in China, with revenue and volumes declining by 16.8%.

$BUDMedAI 8/10

AB InBev: 22% EPS Growth as China Slides: Rapid Earnings Reaction

AB InBev (BUD) reported Q3 revenue of $16.5B (+4.9% organic) and underlying EPS of $1.21 (+22.4%). Normalized EBITDA rose 3.9% to $5.96B, but margins narrowed. Premium beers like Corona and Michelob Ultra drove revenue growth, while China and the U.S. underperformed. Lower financing costs and currency effects boosted earnings. The board raised the interim dividend to 0.40 euros per share.